Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.19 USD | +0.81% | +3.19% | -9.81% |
Financials (USD)
Sales 2024 * | 134M | Sales 2025 * | 218M | Capitalization | 794M |
---|---|---|---|---|---|
Net income 2024 * | -211M | Net income 2025 * | -134M | EV / Sales 2024 * | 4.79 x |
Net cash position 2024 * | 151M | Net cash position 2025 * | 175M | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
-3.93
x | P/E ratio 2025 * |
-6.81
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.12% |
Latest transcript on REGENXBIO Inc.
1 day | +0.81% | ||
1 week | +3.19% | ||
Current month | -23.16% | ||
1 month | -27.01% | ||
3 months | +27.28% | ||
6 months | +12.59% | ||
Current year | -9.81% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Mills
FOU | Founder | 49 | 08-07-15 |
Vit Vasista
DFI | Director of Finance/CFO | 56 | 09-07-31 |
Chief Tech/Sci/R&D Officer | - | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 21-09-02 |
David Stump
BRD | Director/Board Member | 74 | 15-10-14 |
Director/Board Member | 71 | 15-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.76% | 16 M€ | -8.49% | ||
0.25% | 27 M€ | -5.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 16.19 | +0.81% | 305,658 |
24-04-25 | 16.06 | +0.12% | 604,238 |
24-04-24 | 16.04 | +0.88% | 425,390 |
24-04-23 | 15.9 | +1.66% | 360,158 |
24-04-22 | 15.64 | -0.32% | 437,246 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.81% | 794M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RGNX Stock